BCL2L1 and chronic myelogenous leukemia, BCR-ABL1 positive: A Novel CIP2A and BCL-XL Clinical Diagnostic Toolkit to Predict Disease Progression and Treatment-Free Remission in Chronic Myeloid Leukaemia.